Shanghai Bioprofile
Latest round
- Series A
Last raised
- Aug 2023
Total raised
- Undisclosed
Investors
- 2
About Shanghai Bioprofile
Established in 2017 and based in Shanghai, China, Shanghai Bioprofile is a provider of precision medicine services that provides proteomics, metabolomics, genomics and transcriptome technical services. The company has been recognized as a National High-tech Enterprise, and has obtained ISO9001 quality system certification, 11 patents and 10 registered trademarks. It has strategic cooperation with Wuhan University, Peking University, Fudan University, Ruijin Hospital, Wuhan Institute of Virology, and other universities, hospitals and institutes. The company's technology platforms include Triple-TOF 5600, QE-HF X, GC-MS, Orbitrap_Velos, Orbitrap Fusion Lumos, timsTOF Pro, and Q-Extacive HF. The platforms are capable of providing scientific research services and medical testing services in proteomics, metabolomics, genomics and transcriptomics, involving multiple applications such as precision diagnostics, precision medication, and precision screening of drug targets. Shanghai Bioprofile will focus on the R&D and production of Class II and Class III reagent kits, and will set up a 3,000 square meters clinical mass spectrometry-related GMP workshop and medical laboratory, as well as IVD-specific R&D laboratories and research service laboratories.
Who invested in Shanghai Bioprofile
2 investors across 1 round
See all investors in Shanghai Bioprofile
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 25, 2023
Amount
Undisclosed
Investors
Questions about Shanghai Bioprofile
Who invested in Shanghai Bioprofile?
Shanghai Bioprofile has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Shanghai Bioprofile raised?
Shanghai Bioprofile has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Shanghai Bioprofile last raise money?
Shanghai Bioprofile's most recent round on record is a Series A, in Aug 2023.
What does Shanghai Bioprofile do?
Established in 2017 and based in Shanghai, China, Shanghai Bioprofile is a provider of precision medicine services that provides proteomics, metabolomics, genomics and transcriptome technical services.
Where is Shanghai Bioprofile headquartered?
Shanghai Bioprofile is headquartered in Shanghai, China.
Which VCs invest in companies like Shanghai Bioprofile?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Shanghai Bioprofile's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Shanghai Bioprofile? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.